ORKA
Oruka Therapeutics, Inc. · Healthcare · Market cap $5.3B
Insiders sold $22.0M net in the last 90 days ·5 sellers, 0 buyers· 14 of 17 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 21, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$337.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Oct 21, 2026
Quinlan Paul T
Oruka Therapeutics, Inc. (ORKA) has 49 SEC Form 4 filings (178 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Oct 21, 2026.
Inside the rolling window, 7 insiders at Oruka Therapeutics, Inc. reported no open-market purchases and 45 open-market sales totaling $337.7M. The most active filer is Chief Medical Officer Goncalves Joana with 11 filings. Insiders have net sold $335.6M over the trailing 6 months. The most recent open-market filing is a sale of 9,000 shares by General Counsel Quinlan Paul T, dated Oct 20, 2026, worth $707K.
- Industry:Biotechnology
- CEO:Lawrence Otto Klein
- Employees:68
- HQ:Menlo Park, CA, US
- IPO:1997-08-08
| Source | |||||||
|---|---|---|---|---|---|---|---|
| General Counsel | Sale | 9,000 | $707K | Oct 21 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 7,000 | $524K | Oct 15 | +8.2% | SEC ↗ | |
| Senior Vice President, Finance | Sale | 9,999 | $806K | Oct 13 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 25,000 | $2.1M | Oct 2 | — | SEC ↗ | |
| Senior Vice President, Finance | Sale | 533 | $51K | Sep 21 | — | SEC ↗ | |
| General Counsel | Sale | 10,000 | $936K | Sep 21 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 7,947 | $734K | Sep 15 | — | SEC ↗ | |
| Senior Vice President, Finance | Sale | 9,459 | $872K | Sep 15 | — | SEC ↗ | |
| Senior Vice President, Finance | Sale | 560 | $54K | Sep 15 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 2,452 | $235K | Sep 15 | — | SEC ↗ | |
| General Counsel | Sale | 1,039 | $99K | Sep 15 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 906 | $87K | Sep 15 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 5,000 | $459K | Sep 1 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 75,000 | $6.9M | Sep 1 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 7,000 | $783K | Aug 17 | — | SEC ↗ | |
| General Counsel | Sale | 52,000 | $5.6M | Aug 14 | — | SEC ↗ | |
| Senior Vice President, Finance | Sale | 10,000 | $1.1M | Aug 14 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 7,000 | $604K | Jul 15 | — | SEC ↗ | |
| Senior Vice President, Finance | Sale | 9,999 | $846K | Jul 13 | — | SEC ↗ | |
| Director, 10% Owner | Sale | 3,553,410 | $300.0M | Jul 2 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 5,000 | $472K | Jul 1 | — | SEC ↗ | |
| Senior Vice President, Finance | Sale | 1,587 | $128K | Jun 22 | — | SEC ↗ | |
| Senior Vice President, Finance | Sale | 9,459 | $660K | Jun 15 | — | SEC ↗ | |
| Senior Vice President, Finance | Sale | 395 | $28K | Jun 15 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 7,947 | $551K | Jun 15 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ORKA have?
Oruka Therapeutics, Inc. (ORKA) has 49 SEC Form 4 filings (178 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Oct 21, 2026.
When was the most recent SEC Form 4 filing for ORKA?
The most recent Form 4 filing for ORKA on Tracefour is dated Oct 21, 2026.
Who is the most active insider at ORKA?
The most active SEC Form 4 filer at ORKA in the rolling window is Chief Medical Officer Goncalves Joana, with 11 filings.
What is the net insider flow at ORKA over the last 6 months?
Over the trailing 180 days, insiders at ORKA have net sold $335.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ORKA in the current window?
Inside the rolling window, insiders at ORKA bought $0 and sold $337.7M based on SEC Form 4 filings.
Can I get alerts for ORKA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Oruka Therapeutics, Inc. (ORKA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Oruka Therapeutics, Inc. is in the Healthcare sector.